Protein Sequencing Market Primed for Significant Growth Prospects
The protein
sequencing market is estimated to be valued at US$ 1.9 Bn in 2022 and is
expected to exhibit a CAGR of 11.2% over the forecast period 2023-2030, as
highlighted in a new report published by Coherent Market Insights.
Market Overview:
The protein sequencing market consists of technologies and consumables used for
determining the amino acid sequence of proteins. Protein sequencing finds
widespread application in proteomics research, biotherapeutics development and
clinical diagnostics. Advances in mass spectrometry platforms have accelerated
protein sequencing workflows, enabling identification and characterization of
thousands of proteins in a single experiment.
Market Dynamics:
Rising government funding for proteomics and biomarker research worldwide
represents a key factor driving the protein sequencing market. Many public and
private funding agencies are supporting the development of advanced tools and
technologies for large-scale protein analysis. For instance, the National
Institutes of Health allocated over US$ 650 million for the Human Proteome
Project in 2022. In addition, growing demand for personalized medicines has
boosted pharmaceutical R&D investment in target identification and
validation using protein sequencing methods. Technologies such as mass
spectrometry enable evaluation of protein expression changes associated with
disease pathogenesis, fuelling their incorporation in preclinical drug
discovery.
Market Key Trends:
Protein sequencing market is witnessing increasing adoption of
next-generation sequencing technology. NGS provides high-throughput
capabilities for sequencing proteins at a much faster rate and lower cost as
compared to conventional Sanger sequencing. Sanger sequencing faces limitations
such as requirement of prior knowledge of sequence and high costs. The
introduction of NGS platforms such as Illumina sequencing and Ion Torrent has
significantly increased the sequencing output and reduced the time and expenses
involved in protein sequencing. Additionally, growing applications of protein
sequencing in areas such as proteomics, drug discovery, immunology and cancer
research is driving the adoption of advanced protein sequencing methods.
SWOT Analysis:
Strengths: Next generation sequencing technology provides high-throughput
capabilities and lowers the cost of protein sequencing.
Weaknesses: Requirement of large capital investment and advanced data analytics
skills for NGS-based protein sequencing.
Opportunities: Growing applications in proteomics, drug discovery, cancer
research and immunology are expanding the scope of protein sequencing.
Threats: High risks of misinterpretation of large genomic and proteomic data
generated through NGS without comprehensive bioinformatics analysis.
Key Takeaways:
Global
Protein Sequencing Market Size is expected to witness high growth,
exhibiting CAGR of 11.2% over the
forecast period, due to increasing demand for advanced protein analysis in
proteomics and drug discovery research.
Regional analysis: North America dominates the global protein sequencing market
led by presence of major players and growing proteomics research in the region.
The Asia Pacific region also offers lucrative opportunities for market
expansion over the coming years supported by increasing investments in
healthcare sector of developing countries like India and China.
Key players: Key players operating in the protein sequencing market are Agilent
Technologies, Thermo Fisher Scientific, SGS S.A., Shimadzu Corp, Waters Corp.,
Bio-Rad Laboratories, Bruker Corporation, Charles River Laboratories, Selvita,
Rapid Novor Inc. These companies are focusing on launching innovative
sequencing instruments and services to expand their market share.
The protein
sequencing market is estimated to be valued at US$ 1.9 Bn in 2022 and is
expected to exhibit a CAGR of 11.2% over the forecast period 2023-2030, as
highlighted in a new report published by Coherent Market Insights.
Market Overview:
The protein sequencing market consists of technologies and consumables used for
determining the amino acid sequence of proteins. Protein sequencing finds
widespread application in proteomics research, biotherapeutics development and
clinical diagnostics. Advances in mass spectrometry platforms have accelerated
protein sequencing workflows, enabling identification and characterization of
thousands of proteins in a single experiment.
Market Dynamics:
Rising government funding for proteomics and biomarker research worldwide
represents a key factor driving the protein sequencing market. Many public and
private funding agencies are supporting the development of advanced tools and
technologies for large-scale protein analysis. For instance, the National
Institutes of Health allocated over US$ 650 million for the Human Proteome
Project in 2022. In addition, growing demand for personalized medicines has
boosted pharmaceutical R&D investment in target identification and
validation using protein sequencing methods. Technologies such as mass
spectrometry enable evaluation of protein expression changes associated with
disease pathogenesis, fuelling their incorporation in preclinical drug
discovery.
Market Key Trends:
Protein sequencing market is witnessing increasing adoption of
next-generation sequencing technology. NGS provides high-throughput
capabilities for sequencing proteins at a much faster rate and lower cost as
compared to conventional Sanger sequencing. Sanger sequencing faces limitations
such as requirement of prior knowledge of sequence and high costs. The
introduction of NGS platforms such as Illumina sequencing and Ion Torrent has
significantly increased the sequencing output and reduced the time and expenses
involved in protein sequencing. Additionally, growing applications of protein
sequencing in areas such as proteomics, drug discovery, immunology and cancer
research is driving the adoption of advanced protein sequencing methods.
SWOT Analysis:
Strengths: Next generation sequencing technology provides high-throughput
capabilities and lowers the cost of protein sequencing.
Weaknesses: Requirement of large capital investment and advanced data analytics
skills for NGS-based protein sequencing.
Opportunities: Growing applications in proteomics, drug discovery, cancer
research and immunology are expanding the scope of protein sequencing.
Threats: High risks of misinterpretation of large genomic and proteomic data
generated through NGS without comprehensive bioinformatics analysis.
Key Takeaways:
Global
Protein Sequencing Market Size is expected to witness high growth,
exhibiting CAGR of 11.2% over the
forecast period, due to increasing demand for advanced protein analysis in
proteomics and drug discovery research.
Regional analysis: North America dominates the global protein sequencing market
led by presence of major players and growing proteomics research in the region.
The Asia Pacific region also offers lucrative opportunities for market
expansion over the coming years supported by increasing investments in
healthcare sector of developing countries like India and China.
Key players: Key players operating in the protein sequencing market are Agilent
Technologies, Thermo Fisher Scientific, SGS S.A., Shimadzu Corp, Waters Corp.,
Bio-Rad Laboratories, Bruker Corporation, Charles River Laboratories, Selvita,
Rapid Novor Inc. These companies are focusing on launching innovative
sequencing instruments and services to expand their market share.
Comments
Post a Comment